Woodline Partners’s Ascendis Pharma A/S ASND Stock Holding History

Woodline Partners’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.4M	Buy	102,469 +8	+0%	+$1.79K	0.09%	304
2025 Q4	$21.8M	Hold	102,461	–	–	0.08%	293
2025 Q3	$20.4M	Sell	102,461 -202,993	-66%	-$37.9M	0.1%	277
2025 Q2	$52.7M	Buy	305,454 +648	+0.2%	+$106K	0.28%	87
2025 Q1	$47.5M	Sell	304,806 -12,836	-4%	-$1.83M	0.31%	94
2024 Q4	$43.7M	Buy	317,642 +82,624	+35%	+$10.9M	0.3%	97
2024 Q3	$35.1M	Buy	235,018 +36,252	+18%	+$4.9M	0.3%	109
2024 Q2	$27.1M	Buy	198,766 +2,736	+1%	+$372K	0.26%	120
2024 Q1	$29.6M	Buy	196,030 +179,881	+1,114%	+$25.7M	0.27%	115
2023 Q4	$2.03M	Buy	+16,149	New	+$1.61M	0.02%	377
2023 Q2	–	Sell	-304,796	Closed	-$32.7M	–	635
2023 Q1	$32.7M	Buy	304,796 +209,683	+220%	+$24M	0.44%	64
2022 Q4	$11.6M	Sell	95,113 -116,280	-55%	-$13.5M	0.16%	185
2022 Q3	$21.8M	Buy	211,393 +105,267	+99%	+$9.98M	0.31%	93
2022 Q2	$9.87M	Sell	106,126 -5,886	-5%	-$555K	0.15%	179
2022 Q1	$13.1M	Sell	112,012 -112,437	-50%	-$13M	0.21%	143
2021 Q4	$30.2M	Buy	+224,449	New	+$33.4M	0.43%	50
2020 Q1	–	Sell	-55,284	Closed	-$7.69M	–	139
2019 Q4	$7.69M	Buy	+55,284	New	+$6.14M	0.31%	78

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Woodline Partners's ASND Position: Q1 2026 in Review

Woodline Partners increased its Ascendis Pharma A/S (ASND) stake by 0.01% in Q1 2026, buying an estimated $1.79K and bringing the position to 102,469 shares worth $23.4M. The position accounts for 0.09% of the portfolio, ranked #304.

Woodline Partners first reported a position in ASND in Q4 2019 and has held it in 17 quarters since. The position peaked at $52.7M in Q2 2025. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Woodline Partners held 102,469 shares of Ascendis Pharma A/S worth $23.4M as of Q1 2026.
Woodline Partners bought 8 Ascendis Pharma A/S shares in Q1 2026, an estimated $1.79K.
Ascendis Pharma A/S made up 0.09% of Woodline Partners's portfolio in Q1 2026, its #304 holding.
Woodline Partners first reported a position in Ascendis Pharma A/S in Q4 2019 and has held it in 17 quarters since.
Woodline Partners's Ascendis Pharma A/S position peaked at $52.7M in Q2 2025.
273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.